Elevance Health (NYSE:ELV – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday. A number ...

Elevance Health Inc. closed 26.44% below its 52-week high of $567.26, which the company reached on September 3rd.

Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ...

Elevance Health (ELV) stock rises as CFO cites underestimated Q1 profit forecasts from analysts for the company at Barclays ...

We recently compiled a list of the Top 10 Health Insurance Stocks To Buy. In this article, we are going to take a look at ...

Shares of Elevance Health Inc. ELV shed 2.61% to $411.04 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.49% to 5,599.30 ...

In a regulatory filing, Elevance Health (ELV) disclosed that its officers will speak with investors over the next several weeks. During these ...

In its fourth quarter 2024 investor letter, Artisan Select Equity Fund emphasized stocks such as Elevance Health, Inc. (NYSE:ELV). Elevance Health, Inc. (NYSE:ELV) is a health benefits company ...

In its fourth quarter 2024 investor letter, GreensKeeper Asset Management emphasized stocks such as Elevance Health, Inc. (NYSE:ELV) in the fourth quarter 2024 investor letter. Elevance Health ...

Elevance Health (ELV) shares soared 3.1% in the last trading session to close at $422.04. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...

Many stock analysts see Indianapolis-based Elevance’s recent struggles as an opportunity. Thirteen of 24 analysts tracked by The Wall Street Journal rate the health insurer as a buy.